CELL INTELLIGENCE · 肿瘤细胞治疗研究

下一代 CAR-NK 细胞治疗：工程化策略、转化挑战与肿瘤免疫治疗的未来展望

Next-generation CAR-NK cell therapy: engineering strategies, translational challenges, and future perspectives in cancer immunotherapy.

结直肠癌免疫治疗耐药：治疗策略与生物标志物指导的方法

Immunotherapy resistance in colorectal cancer: therapeutic strategies and biomarker-guided approaches.

推进实体瘤 CAR 细胞疗法：挑战、治疗策略和展望

Advancing CAR-based cell therapies for solid tumours: challenges, therapeutic strategies, and perspectives.

装甲 CAR-T 细胞抗耗竭：胶质母细胞瘤的工程化策略

Armoring CAR-T Cells Against Exhaustion: Engineering Strategies for Glioblastoma.

结直肠癌的新免疫治疗方法：聚焦于 CAR-T 细胞、BiTE 和溶瘤病毒

New immunotherapy approaches for colorectal cancer: focusing on CAR-T cell, BiTE, and oncolytic viruses.

横纹肌肉瘤中的 CAR-T 细胞免疫治疗

CAR-T cell immunotherapy in rhabdomyosarcoma.

通过整合这些进展，合理设计的多模式治疗有望克服耐药机制并改善难治性横纹肌肉瘤的结局，为这种历史上难以治愈的恶性肿瘤带来希望。

转化癌症研究中的光遗传学技术

Optogenetic technologies in translational cancer research.

肿瘤诱导的免疫逃逸机制与转化免疫治疗策略

Tumor-induced immune escape mechanisms and translational immunotherapeutic strategies.

基于抗体、T 细胞受体和适配体的双特异性免疫治疗：作用机制、不良反应与未来展望

Bispecific immunotherapy based on antibodies, T-cell receptors, and aptamers: mechanisms of action, adverse effects, and future perspectives.

肺癌基因治疗的进展：从遗传学洞见到临床应用

Advancements in gene therapy for lung cancer: from genetic insights to clinical applications.